IGM Biosciences, Inc. (IGMS) Financials

Stock symbol IGMS is outdated, potentially delisted? Maybe it is available on other exchange?

IGMS Assets vs Liabilities

Date	Assets	Liabilities
June 30, 2025	107.0 million	6.1 million
March 31, 2025	206.9 million	206.2 million
Dec. 31, 2024	265.7 million	217.5 million
Sept. 30, 2024	304.5 million	225.6 million

IGMS Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
June 30, 2025	-50.8 million	2.7 million
March 31, 2025	-32.6 million	5.5 million
Dec. 31, 2024	-35.7 million	5.7 million
Sept. 30, 2024	-39.7 million	16.2 million

IGMS Net Income

No data available :(

IGMS Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
June 30, 2025	104.3 million	-	-
March 31, 2025	152.1 million	36.9 million	44.0 million
Dec. 31, 2024	183.8 million	38.1 million	45.2 million
Sept. 30, 2024	218.8 million	39.2 million	45.9 million

IGMS Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
June 30, 2025	61.8 million
March 31, 2025	61.2 million
Dec. 31, 2024	60.5 million
Sept. 30, 2024	60.7 million

IGMS Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
June 30, 2025	1000	4.4 million	8.5 million	-
March 31, 2025	31000	22.3 million	11.0 million	-
Dec. 31, 2024	862000	28.9 million	10.5 million	-
Sept. 30, 2024	1.3 million	46.1 million	18.8 million	-

IGMS Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
June 30, 2025	143.6 million	441000
March 31, 2025	499000	2.4 million
Dec. 31, 2024	412000	2.4 million
Sept. 30, 2024	516000	-

IGMS

Price: $1.27

52 week price:

0.92

22.50

Earnings Per Share: -0.90 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 224815

Market Capitalization: 76.6 million

Links:

IGMS on Yahoo Finance